Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Drugstore.com Inc. (“Drugstore.com” or the “Company”) (NasdaqGS: DSCM) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Walgreen Co. (NYSE: WAG) for approximately $429 million in cash. The proposed transaction only offers Drugstore.com shareholders $3.80 in cash for each Drugstore.com share they hold. Request more information now by clicking here: www.faruqilaw.com/DSCM Whether the Drugstore.com’s Board of Directors breached their fiduciary duties to Drugstore.com’s stockholders by failing to conduct an adequate and fair sales process to sell the Company prior to agreeing to this proposed transaction, whether the proposed transaction undervalues Drugstore.com’s shares and by how much this proposed transaction undervalues the Company to the detriment of Drugstore.com shareholders are the key focus of this investigation. Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, through all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients. If you own common stock in Drugstore.com and wish to obtain additional information, please visit us at www.faruqilaw.com/DSCM or contact Juan E. Monteverde, Esq. either via e-mail at email@example.com or by telephone at (877) 247-4292 or (212) 983-9330. Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.